Use of Stenting in Living Donor Kidney Transplantation: Does It Reduce Vesicoureteral Complications?

• Published in: Transplantation proceedings 2011-06, Vol.43 (5), p.1623-1626
• Main Authors: Dols, L.F.C, Terkivatan, T, Kok, N.F.M, Tran, T.C.K, Weimar, W, IJzermans, J.N.M, Roodnat, J.I
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Biological and medical sciences; Female; Fundamental and applied biological sciences. Psychology; Fundamental immunology; Humans; Kidney Transplantation; Living Donors; Male; Medical sciences; Middle Aged; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects); Stents; Surgery; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases; Surgery of the urinary system; Tissue, organ and graft immunology; Urinary Bladder Diseases - prevention & control; Young Adult
• ISSN: 0041-1345; 1873-2623
• DOI: 10.1016/j.transproceed.2011.01.186

Abstract The risk of urologic complications after kidney transplantation is 0% to 30%. We studied the impact of prophylactic stent placement during transplantation by assessing the necessity for a percutaneous nephrostomy (PCN) after living kidney transplantation. From January 2003 to December 2007, 342 living donor kidney transplantations were performed. Intra- and postoperative data were collected retrospectively from 285 patients with stent and 57 without. Baseline characteristics were not significantly different between groups, except for the number of previous transplantations: 31 (11%) patients with versus 16 (28%) without stent had a history of >1 transplantation ( P < .001). From patients with PCN, 55 (87%) patients in the stented group received a PCN